tofacitinib우선순위 낮음근거 검토기타
LITERATURE DETAIL · PMID 42616227
Real-world effectiveness of tofacitinib in monotherapy or in combination with csDMARDs in patients with rheumatoid arthritis: A collaboration between Dutch registries (TOFADUDAP study).
Real-world effectiveness of tofacitinib in monotherapy or in combination with csDMARDs in patients with rheumatoid arthritis: A collaboration between Dutch registries (TOFADUDAP study).
- 저자
- Isabell S Nevins, Herman Kasper Glas, Floor Reimann, Reinhard Bos, Marieke P D de Buck, K Wiepke Drossaers-Bakker
- 저널
- Clinical rheumatology
- 공개일
- 2026 Aug 19
- 연구 유형
- 기타
- DOI
- 10.1007/s10067-026-08362-x
문헌 요약
To compare real-world effectiveness of tofacitinib monotherapy to adalimumab monotherapy, and tofacitinib and adalimumab in combination with csDMARDs in Rheumatoid Arthritis (RA) subgroups. Retrospective routine care data was used from six Dutch cohorts for RA patients who initiated tofacitinib or adalimumab between 2001 and 2022. Drug survival of tofacit…
PV 검토 포인트
누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.